Silvia Ferrari - Concepedia

Author

Silvia Ferrari

Ospedale Papa Giovanni XXIII ORCID

Also Known As

Ferrari S, Ferrari, S, Ferrari, Silvia, Ferrari, Silvia Elizabeth, S Ferrari, S. FERRARI, S. Ferrari, Silvia Ferrari

137

Publications

Citations

H-Index

Concepts

All Affiliations

Ospedale Papa Giovanni XXIII Istituti di Ricovero e Cura a Carattere Scientifico University of Milan Baxter (Austria)Azienda Ospedaliera San Gerardo

About

Silvia Ferrari is an author at Ospedale Papa Giovanni XXIII specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	838
2	Engineering	4	4	204
3	Natural Sciences	2	2	59
4	Health Sciences	1	1	11
5	Allergy	1	1	44

Silvia Ferrari

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity Silvia Ferrari, Friedrich Scheiflinger, Manfred Rieger, Blood	2006	292
IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura Silvia Ferrari, Geert C. Mudde, Michael Rieger, Journal of Thrombosis and Haemostasis ThrombosisIgg Subclass DistributionAnti‐adamts13 AntibodiesImmunologyHematology	2009	191
Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities Chiara F. Magnani, Giuseppe Gaipa, Federico Lussana, Journal of Clinical Investigation	2020	183
von Willebrand factor cleaving protease (ADAMTS‐13) and ADAMTS‐13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura Flora Peyvandi, Silvia Ferrari, Silvia Lavoretano, British Journal of Haematology ImmunologyPathologyThrombosisVon Willebrand FactorAdamts13 Gene	2004	154
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study Armando Santoro, Vittorio Gebbia, Tiziana Pressiani, Annals of Oncology MedicineGemcitabine Versus GemcitabineBiliary CancerPharmacologyPhase Ii Study	2014	116
Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation Barbara Plaimauer, Jakob Fuhrmann, Gabriele Mohr, Blood	2005	109
Relationship between sediment distribution and Posidonia oceanica seagrass Giovanni De Falco, Silvia Ferrari, Gianluigi Cancemi, Geo-Marine Letters SeagrassEngineeringSediment ProcessOceanographyMarine Biology	2000	86
Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura Silvia Ferrari, Kristina Palavra, B. Gruber, Haematologica Clinical ImmunologyImmunodeficienciesAdamts13 InhibitorImmunologyPathology	2013	59
Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13) Armando Tripodi, Flora Peyvandi, Veena Chantarangkul, Journal of Thrombosis and Haemostasis Proteomic TechnologyEngineeringVon Willebrand FactorBioanalysisMolecular Biology	2008	56
Graphene, other carbon nanomaterials and the immune system: toward nanoimmunity-by-design Arianna Gazzi, Laura Fusco, Marco Orecchioni, Journal of Physics Materials NanoparticlesNanotherapeuticsEngineeringGraphene WorldwideImmunology	2020	44

Page 1